✦ LIBER ✦

PCN32 ECONOMIC EVALUATION OF SUNITINIB, SORAFENIB, BEVACIZUMAB/ INTERFERON ALPHA AND TEMSIROLIMUS IN FIRST LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN ISRAEL

✍ Scribed by D Greenberg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN29 ECONOMIC EVALUATION OF SUNITINIB F

✍ U Munir; Á Benedict; B Borgman; R Sandin; U Harmenberg; A Ullén; P Sandström 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCN18 SUNITINIB VS. INTERFERON-ALPHA (IF

✍ E Remák; R Brown; S Negrier; RJ Motzer; ST Kim; C Charbonneau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

PCN70 COST EFFECTIVENESS ANALYSIS OF SUN

✍ E Remák; H Vioix; R Sandin; U Harmenberg; A Ullén; P Sandström 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCN13 A COMPARATIVE EFFECTIVENESS ASSESS

✍ GH Mickisch; B Schwander; B Escudier; J Bellmunt; P Maroto; C Porta; S Walzer; U 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN59 Cost-Effectiveness of Pazopanib Ve

✍ Pepe, C.; Paladini, L.; Sedlmayer, C.; Machado, M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN26 COST-EFFECTIVENESS AND COST-UTILIT

✍ Salinas-Escudero, G; Contreras-Hernandez, I; Mould-Quevedo, J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB